Search results
Why Roche Holdings Stock Popped Today
Motley Fool via Yahoo Finance· 2 months agoShares of Swiss pharmaceuticals giant Roche Holdings (OTC: RHHBY) stock popped 2.5% in early trading Thursday before giving back about half of its gains....
Drug Giant Roche Skids As Covid Products Decline Weighs On Sales, Guidance
Investor's Business Daily· 8 months agoRoche stock skidded early Thursday after the Swiss drugmaker said declining demand for Covid...
Roche Follows Merck, Sanofi Into A Red-Hot Immunology Space With A $7.1 Billion Buyout
Investor's Business Daily· 8 months agoSwiss drugmaker Roche said Monday it has agreed to buy an experimental immunology drug from Roivant...
How Roche Just Cut Top 1% Biotech Stock TG Therapeutics Down A Peg
Investor's Business Daily· 11 months agoRoche unveiled positive results Thursday for a rival to TG Therapeutics' one-hour infusion for...
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
Motley Fool· 1 year agoRoche Holding (OTC: RHHBY) and Gilead Sciences (NASDAQ: GILD) both saw increased sales during the...
Top Swiss Dividend Stocks To Consider In June 2024
Simply Wall St. via Yahoo Finance· 20 hours agoAmid fluctuating market conditions and cautious investor sentiment in Switzerland, as highlighted by recent movements in the SMI index and economic...
Roche Stock Rises On $3.1 Billion Deal For Obesity Drugmaker
Investor's Business Daily· 6 months agoRoche said Monday it will spend up to $3.1 billion to acquire Carmot Therapeutics, a biotech firm...
Roche joins obesity drug chase with $2.7B deal for startup Carmot
BioPharma Dive via Yahoo Finance· 6 months agoRoche on Monday agreed to acquire biotechnology company Carmot Therapeutics in a deal that bulks up...
Roche CFO flags need to bolster late-stage drug development
Reuters via Yahoo News· 11 months agoSwiss drugmaker Roche needs to have better drug development projects in advanced stages to bolster...
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Zacks via Yahoo Finance· 2 months agoRoche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue...